Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 111

Similar articles for PubMed (Select 24980508)

1.

Defining criteria for disease activity states in nonsystemic juvenile idiopathic arthritis based on a three-variable juvenile arthritis disease activity score.

Consolaro A, Negro G, Chiara Gallo M, Bracciolini G, Ferrari C, Schiappapietra B, Pistorio A, Bovis F, Ruperto N, Martini A, Ravelli A.

Arthritis Care Res (Hoboken). 2014 Nov;66(11):1703-9. doi: 10.1002/acr.22393.

PMID:
24980508
2.

Arthritis mutilans in a patient with juvenile idiopathic arthritis.

Nakamura J, Nagashima T, Yoshio T, Minota S.

Intern Med. 2015;54(6):689. doi: 10.2169/internalmedicine.54.3982. Epub 2015 Jan 15. No abstract available.

3.

Is there hope for juvenile idiopathic arthritis patient-reported outcomes in support of clinical decisions?

Burchette RJ.

J Rheumatol. 2015 Mar;42(3):358-9. doi: 10.3899/jrheum.141621. No abstract available.

PMID:
25729040
4.

Optimisation of disease assessments in juvenile idiopathic arthritis.

Consolaro A, Schiappapietra B, Dalprà S, Calandra S, Martini A, Ravelli A.

Clin Exp Rheumatol. 2014 Sep-Oct;32(5 Suppl 85):S-126-30. Epub 2014 Oct 30. Review.

PMID:
25365101
5.

Using the Juvenile Arthritis Disease Activity Score based on erythrocyte sedimentation rate or C-reactive protein level: results from the Portuguese register.

Mourão AF, Santos MJ, Melo-Gomes J, Martins FM, Costa JA, Ramos F, Brito I, Duarte C, Figueira R, Figueiredo G, Furtado C, Lopes A, Oliveira M, Rodrigues A, Salgado M, Sousa M, Branco JC, Fonseca JE, Canhão H.

Arthritis Care Res (Hoboken). 2014 Apr;66(4):585-91. doi: 10.1002/acr.22215.

PMID:
25354266
6.

Description of active joint count trajectories in juvenile idiopathic arthritis.

Berard RA, Tomlinson G, Li X, Oen K, Rosenberg AM, Feldman BM, Yeung RS, Bombardier C.

J Rheumatol. 2014 Dec;41(12):2466-73. doi: 10.3899/jrheum.130835. Epub 2014 Oct 1.

PMID:
25274882
7.

Periostin gene variants are associated with disease course and severity in juvenile idiopathic arthritis.

Covone AE, Solari N, Malattia C, Pop V, Martini A, Ravelli A, Ravazzolo R.

Clin Exp Rheumatol. 2014 Sep-Oct;32(5):747-53. Epub 2014 Sep 19.

PMID:
25236364
8.

Safety and efficacy of etanercept in children with juvenile idiopathic arthritis below the age of 2 years.

Windschall D, Müller T, Becker I, Horneff G.

Rheumatol Int. 2015 Apr;35(4):613-8. doi: 10.1007/s00296-014-3125-9. Epub 2014 Sep 11.

PMID:
25208527
9.

The biologic basis of clinical heterogeneity in juvenile idiopathic arthritis.

Eng SW, Duong TT, Rosenberg AM, Morris Q, Yeung RS; REACCH OUT and BBOP Research Consortia.

Arthritis Rheumatol. 2014 Dec;66(12):3463-75. doi: 10.1002/art.38875.

10.

The association between low socioeconomic status with high physical limitations and low illness self-perception in patients with juvenile idiopathic arthritis: results from the Childhood Arthritis Prospective Study.

Verstappen SM, Cobb J, Foster HE, Fu B, Baildam E, Wedderburn LR, Davidson JE, Ioannou J, Chieng A, Hyrich KL, Thomson W.

Arthritis Care Res (Hoboken). 2015 Mar;67(3):382-9. doi: 10.1002/acr.22466.

PMID:
25187470
11.

Measurement and evaluation of isotypes of anti-citrullinated fibrinogen and anti-citrullinated alpha-enolase antibodies in juvenile idiopathic arthritis.

Moore TL, Gillian BE, Crespo-Pagnussat S, Feller L, Chauhan AK.

Clin Exp Rheumatol. 2014 Sep-Oct;32(5):740-6. Epub 2014 Jul 17.

PMID:
25068682
12.

[Definition of criteria for high disease activity using the Juvenile Rheumatoid Arthritis Disease Activity Score].

Horneff G.

Z Rheumatol. 2014 Jun;73(5):398. German. No abstract available.

PMID:
25057521
13.

Physical activity, functional ability, and disease activity in children and adolescents with juvenile idiopathic arthritis.

Gueddari S, Amine B, Rostom S, Badri D, Mawani N, Ezzahri M, Moussa F, Shyen S, Abouqal R, Chkirat B, Hajjaj-Hassouni N.

Clin Rheumatol. 2014 Sep;33(9):1289-94. doi: 10.1007/s10067-014-2576-4. Epub 2014 Mar 22.

PMID:
24651917
14.

Definition of improvement in juvenile idiopathic arthritis using the juvenile arthritis disease activity score.

Horneff G, Becker I.

Rheumatology (Oxford). 2014 Jul;53(7):1229-34. doi: 10.1093/rheumatology/ket470. Epub 2014 Mar 4.

PMID:
24599918
15.

Self-reported pain and disease symptoms persist in juvenile idiopathic arthritis despite treatment advances: an electronic diary study.

Bromberg MH, Connelly M, Anthony KK, Gil KM, Schanberg LE.

Arthritis Rheumatol. 2014 Feb;66(2):462-9. doi: 10.1002/art.38223.

16.

Limitations in the classification of childhood-onset rheumatoid arthritis.

Ferrell EG, Ponder LA, Minor LS, Angeles-Han ST, Kennedy CW, Rouster-Stevens KA, Rohani-Pichavant M, Vogler LB, Prahalad S.

J Rheumatol. 2014 Mar;41(3):547-53. doi: 10.3899/jrheum.130563. Epub 2014 Feb 1.

PMID:
24488421
17.

The accuracy of the Child and Adolescent Intellectual Disability Screening Questionnaire (CAIDS-Q) in classifying severity of impairment: a brief report.

Murray AL, McKenzie K.

J Intellect Disabil Res. 2014 Dec;58(12):1179-84. doi: 10.1111/jir.12115. Epub 2014 Jan 27.

PMID:
24460964
18.

Detection of enthesitis in children with enthesitis-related arthritis: dolorimetry compared to ultrasonography.

Weiss PF, Chauvin NA, Klink AJ, Localio R, Feudtner C, Jaramillo D, Colbert RA, Sherry DD, Keren R.

Arthritis Rheumatol. 2014 Jan;66(1):218-27. doi: 10.1002/art.38197.

19.

Disease of the year: juvenile idiopathic arthritis-associated uveitis--classification and diagnostic approach.

Tugal-Tutkun I, Quartier P, Bodaghi B.

Ocul Immunol Inflamm. 2014 Feb;22(1):56-63. doi: 10.3109/09273948.2013.871565. Epub 2014 Jan 10. Review.

PMID:
24410427
20.

A randomised controlled trial of the clinical effectiveness, safety and cost-effectiveness of adalimumab in combination with methotrexate for the treatment of juvenile idiopathic arthritis associated uveitis (SYCAMORE Trial).

Ramanan AV, Dick AD, Benton D, Compeyrot-Lacassagne S, Dawoud D, Hardwick B, Hickey H, Hughes D, Jones A, Woo P, Edelsten C, Beresford MW; SYCAMORE Trial Management Group.

Trials. 2014 Jan 9;15:14. doi: 10.1186/1745-6215-15-14.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk